Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-0054 Alone or with G-CSF for Stem Cell Mobilization
NCT01458288Phase 2Completed
- Sponsor
- GPCR Therapeutics
- Start
- Oct 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of burixafor in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by GPCR Therapeutics. Started Oct 2012; status: completed.
02
Drugs
burixafor
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01458288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458288.